Karaca M - Search Results

1

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.

Bilici A, Koca S, Karaagac M, Aydin SG, Eraslan E, Kaplan MA, Ocak B, Goksu SS, Paydas S, Akgul F, Derin S, Ergun Y, Yekeduz E, Erol C, Ozyukseler DT, Demiray AG, Karaca M, Guc ZG, Menekse S, Cinkir HY, Gumusay O, Sakin A, Ozkul O, Demir H, Erdem D, Besiroglu M, Unal OU, Acar R, Koral L, Sahin S, Sakalar T, Bahceci A, Ozveren A, Gunaydin UM, Seker MM, Sunar V, Dal P, Artac M, Turhal S. Bilici A, et al. Among authors: karaca m. J Cancer Res Clin Oncol. 2023 Sep;149(11):8243-8253. doi: 10.1007/s00432-023-04766-3. Epub 2023 Apr 17. J Cancer Res Clin Oncol. 2023. PMID: 37067546

2

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study.

Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Almuradova E, et al. Among authors: karaca m. Cureus. 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119. eCollection 2023 May. Cureus. 2023. PMID: 37216135 Free PMC article.

3

Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.

Karacin C, Sunar V, Urakci Z, Yilmaz A, Ayhan M, Ersoy M, Guven DC, Erturk I, Durmus Y, Karacin P, Boran N, Ustun YE, Meydan M, Dogan M, Oksuzoğlu B, Ates O, Karaca M, Uncu D, Ergun Y, Arik Z. Karacin C, et al. Among authors: karaca m. Future Oncol. 2024 Feb;20(4):207-214. doi: 10.2217/fon-2023-0763. Epub 2024 Feb 8. Future Oncol. 2024. PMID: 38328890

4

Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Yucel OK, Vural E, Alhan N, Vurgun S, Atas U, Yapar D, Alemdar MS, Karaca M, Iltar U, Salim O, Undar L. Yucel OK, et al. Among authors: karaca m. Oncology. 2023;101(11):753-764. doi: 10.1159/000531576. Epub 2023 Jun 26. Oncology. 2023. PMID: 37364535

5

The Relationship Between Controlling Nutritional Assessment Score and Mortality in Patients with Chronic Coronary Syndrome: A Retrospective Study from Türkiye.

Tiryaki MM, Emren SV, Gursoy MO, Kiris T, Esin F, Esen S, Karaca M, Nazli C. Tiryaki MM, et al. Among authors: karaca m. Niger J Clin Pract. 2024 May 1;27(5):612-619. doi: 10.4103/njcp.njcp_769_23. Epub 2024 May 29. Niger J Clin Pract. 2024. PMID: 38842711 Free article.

6

Clinical Presentation and Molecular Characterization of 3 Patients with Vici Syndrome: Two Novel Variants in the EPG5 Gene.

Selamioğlu A, Doğan BY, Balcı MC, Kalaycı T, Karaca M, Ak B, Durmuş A, Körbeyli HK, Gökçay G. Selamioğlu A, et al. Among authors: karaca m. Mol Syndromol. 2024 Jun;15(3):257-268. doi: 10.1159/000536069. Epub 2024 Feb 1. Mol Syndromol. 2024. PMID: 38841323

7

Brown tumors: Retrospective analysis of 26 cases.

Karaca MO, Özyıldıran M, Savran MD, Başarır K, Yıldız HY. Karaca MO, et al. Arch Orthop Trauma Surg. 2024 May 25. doi: 10.1007/s00402-024-05372-9. Online ahead of print. Arch Orthop Trauma Surg. 2024. PMID: 38795187

8

Chondromyxoid fibroma: A retrospective evaluation of 31 cases.

Karaca MO, Özyıldıran M, Alizade R, Başarır K, Yıldız HY. Karaca MO, et al. Jt Dis Relat Surg. 2024 Apr 26;35(2):377-385. doi: 10.52312/jdrs.2024.1620. Epub 2024 Apr 26. Jt Dis Relat Surg. 2024. PMID: 38727118 Free PMC article.

9

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.

Yildirim ME, Karadurmuş N, Ökten İN, Türk HM, Urakçı Z, Arslan Ç, Çelik S, Dane F, Şendur MAN, Bilir C, Karabulut B, Cicin İ, Çubukçu E, Karaca M, Ozcelik M, Artaç M, Tanrikulu E, Alacacioglu A, Açıkgöz Ö, Öven B, Geredeli Ç, Çil T, Harputluoğlu H, Kefeli U, Bozkurt O, Tural D, Sakin A, Yalçın Ş, Gumus M. Yildirim ME, et al. Among authors: karaca m. J Oncol Pharm Pract. 2024 Apr 13:10781552241241004. doi: 10.1177/10781552241241004. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 38613329

10

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.

Karaca M, Salim E, Alemdar MS, Deniz Karaca Ö, Arıcı MÖ. Karaca M, et al. Med Sci Monit. 2024 Mar 28;30:e943750. doi: 10.12659/MSM.943750. Med Sci Monit. 2024. PMID: 38544312 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page